Article
Development and utility of the FDA 'GutProbe' DNA microarray for identification, genotyping and metagenomic analysis of commercially available probiotics.
Journal of applied microbiology - 1 Jun 2015
Patro J N, Ramachandran P, Lewis J L, Mammel M K, Barnaba T, Pfeiler E A, Elkins C A
Abstract excerpt
AIM: Lactic acid bacteria are beneficial microbes added to many food products and dietary supplements for their purported health benefits. Proper identification of bacteria is important to assess safety as well as proper product labelling. A custom microarray (FDA GutProbe) was developed to verify accurate labelling in commercial dietary supplements. METHODS AND RESULTS: Strain-specific attribution was achieved...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
